User profiles for Alexandre B. Cavalcanti
 | Alexandre CavalcantiDiretor, Instituto de Pesquisa, Hospital do Coração Verified email at hcor.com.br Cited by 17703 |
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label …
…, AVS Macedo, B Bronhara, LP Damiani, LM Barbosa… - The Lancet, 2021 - thelancet.com
Background COVID-19 is associated with a prothrombotic state leading to adverse clinical
outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised …
outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised …
Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis
…, O Berwanger, AB Cavalcanti, PF Dequin, B Du… - Jama, 2020 - jamanetwork.com
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX …
Importance Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19)
is associated with substantial mortality and use of health care resources. …
is associated with substantial mortality and use of health care resources. …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
…, DLC Farias, JG PRATS, AB CAVALCANTI… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Background Hydroxychloroquine and azithromycin have been used to treat patients with
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
…, LM Ishihara, D Schneider, D de Souza, AB Cavalcanti… - bmj, 2021 - bmj.com
Objective To determine whether tocilizumab improves clinical outcomes for patients with
severe or critical coronavirus disease 2019 (covid-19). Design Randomised, open label trial. …
severe or critical coronavirus disease 2019 (covid-19). Design Randomised, open label trial. …
Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a …
Importance The effect of high-flow oxygen therapy vs conventional oxygen therapy has not
been established in the setting of severe COVID-19. Objective To determine the effect of high-…
been established in the setting of severe COVID-19. Objective To determine the effect of high-…
Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial
Importance Intravenous fluids are used for almost all intensive care unit (ICU) patients.
Clinical and laboratory studies have questioned whether specific fluid types result in improved …
Clinical and laboratory studies have questioned whether specific fluid types result in improved …
How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials
… We therefore defined, a priori, cardiovascular death, bradycardia needing treatment, and
hypotension needing treatment (see appendix B on bmj.com… Articles by Alexandre B Cavalcanti …
hypotension needing treatment (see appendix B on bmj.com… Articles by Alexandre B Cavalcanti …
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil …
Background The efficacy and safety of azithromycin in the treatment of COVID-19 remain
uncertain. We assessed whether adding azithromycin to standard of care, which included …
uncertain. We assessed whether adding azithromycin to standard of care, which included …
